image_alt_text
4

Shana O. Kelley, Ph.D.

AIMBE College of Fellows Class of 2016
For outstanding contributions to the development of new chip-based sensors for point-of-care molecular analysis

Gene Loss Enhances Metastasis and Cancer Progression

Via Northwestern University | September 29, 2022

Investigators have discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study published in Science Advances.

Metastasis accounts for most cancer-related deaths, yet its underlying mechanisms have remained poorly understood despite recent advances in cancer treatments and care… Continue reading.

New tool harnesses immune cells from tumors to effectively fight cancer

Via News-Medical.Net | January 28, 2022

Northwestern scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively, published in the journal Nature Biomedical Engineering.

Their findings showed a dramatic shrinkage in tumors in mice compared to traditional cell therapy methods. With a novel microfluidic device that could be 3D printed, the team multiplied, sorted through and harvested hundreds of millions of cells, recovering 400 percent more of the tumor-eating cells than current approaches… Continue reading.

Shana O. Kelley, Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | January 20, 2016

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Shana O. Kelley, Ph.D., Distinguished Professor, undefined, University of Toronto, to its College of Fellows. Dr. Kelley was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to the development of new chip-based sensors for point-of-care molecular analysis.